Learning objectives

• Why, how and in whom Lp(a) should be measured
• Management of people with high Lp(a) levels
• The role of Lp(a) in atherosclerotic coronary artery disease
• Future prospects for the treatment of people with high Lp(a) levels

Speakers

Dermot Neely, Retired Lipidologist, HEART UK Trustee
Jai Cegla, Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust

Learning module instructions

This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
After you have successfully completed the test you will be able to download your certificate.

References:

1. Cegla J et al. Atherosclerosis 2019;291:62–70
2. Cegla J et al. Ann Clin Biochem 2021;58:16–21
3. Lp(a) Clinical Guidance (2023). Lp(a) risk calculator. Available at: https://www.lpaclinicalguidance.com/ (accessed December 2024)
4. National Clinical Guideline for stroke for the United Kingdom and Ireland (2023 edition). Available at: https://www.strokeguideline.org/app/uploads/2023/04/National-Clinical-Guideline-for-Stroke-2023.pdf (accessed December 2024)